JPCCM
PCRX icon

J&P (China) Capital Management’s Pacira BioSciences PCRX Stock Holding History

J&P (China) Capital Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,970
Closed -$81K – 18
2015
Q3 		$81K Hold
1,970
– – 0.02% 18
2015
Q2 		$139K Hold
1,970
– – 0.02% 21
2015
Q1 		$175K Buy
+1,970
New +$200K 0.02% 20

Other funds holding PCRX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HCM
Hoplite Capital Management New York $15.1M AUM 27.41% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

J&P (China) Capital Management's PCRX Position: Q4 2015 in Review

J&P (China) Capital Management sold out of Pacira BioSciences (PCRX) in Q4 2015, closing a stake of 1,970 shares — an estimated $81K sold.

J&P (China) Capital Management first reported a position in PCRX in Q1 2015 and held it in 3 quarters. The position peaked at $175K in Q1 2015. 214 funds tracked by Wall St. Rank hold PCRX as of Q4 2015.

  • J&P (China) Capital Management reported no remaining Pacira BioSciences position as of Q4 2015 after selling out during the quarter.
  • J&P (China) Capital Management sold 1,970 Pacira BioSciences shares in Q4 2015, an estimated $81K.
  • J&P (China) Capital Management first reported a position in Pacira BioSciences in Q1 2015 and held it in 3 quarters.
  • J&P (China) Capital Management's Pacira BioSciences position peaked at $175K in Q1 2015.
  • 214 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2015.

Based on J&P (China) Capital Management's 13F filing for Q4 2015, filed 29 Jan 2016.